November 24, 2025 · Form 4 insider transaction
Piekos Brian sold 4,471 shares of KalVista Pharmaceuticals, Inc. at $13.45 per share, a transaction worth $60.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.